[1] Adaptado de: European Monitoring Centre for Drugs and Drug Addiction (2014). Health and social responses for methamphetamine users in Europe, 2. Interactive: methamphetamine global timeline. Acedido a 12 de abril de 2017, em http://www.emcdda.europa.eu/topics/pods/responses-for-methamphetamine-users#panel2.
[2] U.S. Food & Drug Administration (2016). Legal Requirements for the Sale and Purchase of Drug Products Containing Pseudoephedrine, Ephedrine, and Phenylpropanolamine. Acedido a 22 de abril de 2017, em: https://www.fda.gov/Drugs/DrugSafety/InformationbyDrugClass/ucm072423.htm.
[3] Jenner, L. & Lee, N. (2008). Treatment Approaches for Users of Methamphetamine: A Practical Guide for Frontline Workers. Australian Government Department of Health and Ageing, Canberra.
[4] European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). (2015). Methamphetamine drug profile. Acedido a 2 de maio de 2017, em http://www.emcdda.europa.eu/publications/drug-profiles/methamphetamine#chemistry.
[5] INCHEM (1998). Methamphetamine. Acedido a 2 de maio de 2017, em: http://www.inchem.org/documents/pims/pharm/pim334.htm.
[6] Panenka, W. J. et al. (2013). Methamphetamine use: a comprehensive review of molecular, preclinical and clinical findings. Drug and alcohol dependence, 129(3), 167-179.
[7] Kish, S. J. (2008). Pharmacologic mechanisms of crystal meth. Canadian Medical Association Journal, 178(13), 1679-1682.
[8] Halpin, L. E., Collins, S. A., & Yamamoto, B. K. (2014). Neurotoxicity of methamphetamine and 3, 4-methylenedioxymethamphetamine. Life sciences, 97(1), 37-44.
[9] Miller, P. M. (2013). Principles of addiction: comprehensive addictive behaviors and disorders (Vol. 1). Academic Press.
[10] Ballester, J., Valentine, G., & Sofuoglu, M. (2017). Pharmacological treatments for methamphetamine addiction: current status and future directions. Expert Review of Clinical Pharmacology.
[11] Musshoff, F. (2000). Illegal or legitimate use? Precursor compounds to amphetamine and methamphetamine. Drug metabolism reviews, 32(1), 15-44.
[12] Slideshow: Efeitos do uso de metanfetaminas. Imagens retiradas do Programa Faces of Meth™. Disponível em: http://www.mcso.us/facesofmeth/main.htm.
[13] DrugBank (2017). Methamphetamine. Acedido a 2 de maio de 2017, em: https://www.drugbank.ca/drugs/DB01577.
[14] UNSW Sydney: Newsroom. (2016). Number of at-risk adolescents using methamphetamine doubles in five years. Acedido a 10 de maio de 2017, em: http://newsroom.unsw.edu.au/news/health/number-risk-adolescents-using-methamphetamines-doubles-five-years.